Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Crossing the Blood-Brain Barrier with AAVs: What’s After SMA?
The 2009 discovery that the AAV9 serotype can deliver genes across the blood-brain barrier (BBB) spurred the rapid development of a recently FDA-approved gene therapy for spinal muscular atrophy (SMA). The suc...
-
Article
Open AccessSystematic auditing is essential to debiasing machine learning in biology
Biases in data used to train machine learning (ML) models can inflate their prediction performance and confound our understanding of how and what they learn. Although biases are common in biological data, syst...